Drugs for Malaria Industry Outlook, Opportunity And Demand Analysis, Forecast 2020-2026

Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Anti-malarial Drugs are available only with a physician's prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.

The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.

Get Exclusive Sample of this Premium Report @ http://www.amecoresearch.com/sample/200880

The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Drugs for Malaria market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Drugs for Malaria market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Drugs for Malaria market. Readers of the report can become informed about current and future trends of the global Drugs for Malaria market and how they will impact market growth during the forecast period.

Geographic Segmentation

The report offers exhaustive assessment of different region-wise and country-wise Drugs for Malaria markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.

For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Drugs for Malaria market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.

Buy This Premium Report At Special Financial Year End Sale Offer: http://www.amecoresearch.com/discount/200880

Single User Flat 10% Off | Multi-User Flat 15% Off

*Offer Valid Till 31st March 2020*

Market Segmentation by Type and by Application

The report includes a detailed analysis of leading and by Type and by Application segments of the global Drugs for Malaria market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Drugs for Malaria market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Drugs for Malaria market is segmented into

Aryl Aminoalcohol Compounds

Antifolate Compounds

Artemisinin Compounds

Market Segment by Application, the Drugs for Malaria market is segmented into

Prevention

Treatment

Other

This report includes the following manufacturers; we can also add the other companies as you want.

Cipla

Guilin Pharmaceutical

IPCA Laboratories

GlaxoSmithKline

Mylan Labs

Roche

Novartis

Sanofi Aventis

Ajanta Pharma

Any question before placing an order or any customization required, please feel free to contact: Click Here

Table of Content

Global Drugs for Malaria Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
1 Report Overview
1.1 Research Scope
1.2 Top Drugs for Malaria Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Drugs for Malaria Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Aryl Aminoalcohol Compounds
1.3.3 Antifolate Compounds
1.3.4 Artemisinin Compounds
1.4 Market Segment by Application
1.4.1 Global Drugs for Malaria Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Prevention
1.4.3 Treatment
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Drugs for Malaria Revenue (2015-2026)
2.1.1 Global Drugs for Malaria Revenue (2015-2026)
2.1.2 Global Drugs for Malaria Sales (2015-2026)
2.2 Drugs for Malaria Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Drugs for Malaria Sales by Regions (2015-2020)
2.2.2 Global Drugs for Malaria Revenue by Regions (2015-2020)
2.3 Global Top Drugs for Malaria Regions (Countries) Ranking by Market Size
2.4 Drugs for Malaria Industry Trends
2.4.1 Drugs for Malaria Market Top Trends
2.4.2 Market Drivers
2.4.3 Drugs for Malaria Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Drugs for Malaria Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Drugs for Malaria Manufacturers by Sales (2015-2020)
3.1.1 Global Drugs for Malaria Sales by Manufacturers (2015-2020)
3.1.2 Global Drugs for Malaria Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Drugs for Malaria Sales in 2019
3.2 Global Top Manufacturers Drugs for Malaria by Revenue
3.2.1 Global Drugs for Malaria Revenue by Manufacturers (2015-2020)
3.2.2 Global Drugs for Malaria Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drugs for Malaria Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Malaria as of 2019)
3.4 Global Drugs for Malaria Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Drugs for Malaria Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Drugs for Malaria Market
3.7 Key Manufacturers Drugs for Malaria Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Drugs for Malaria Historic Market Review by Type (2015-2020)
4.1.2 Global Drugs for Malaria Sales Market Share by Type (2015-2020)
4.1.3 Global Drugs for Malaria Revenue Market Share by Type (2015-2020)
4.1.4 Drugs for Malaria Price by Type (2015-2020)
4.1 Global Drugs for Malaria Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Drugs for Malaria Sales Forecast by Type (2021-2026)
4.2.3 Global Drugs for Malaria Revenue Forecast by Type (2021-2026)
4.2.4 Drugs for Malaria Price Forecast by Type (2021-2026)

5 Global Drugs for Malaria Market Size by Application
5.1 Global Drugs for Malaria Historic Market Review by Application (2015-2020)
5.1.2 Global Drugs for Malaria Sales Market Share by Application (2015-2020)
5.1.3 Global Drugs for Malaria Revenue Market Share by Application (2015-2020)
5.1.4 Drugs for Malaria Price by Application (2015-2020)
5.2 Global Drugs for Malaria Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Drugs for Malaria Sales Forecast by Application (2021-2026)
5.2.3 Global Drugs for Malaria Revenue Forecast by Application (2021-2026)
5.2.4 Drugs for Malaria Price Forecast by Application (2021-2026)

6 North America
6.1 North America Drugs for Malaria Breakdown Data by Company
6.2 North America Drugs for Malaria Breakdown Data by Type
6.3 North America Drugs for Malaria Breakdown Data by Application
6.4 North America Drugs for Malaria Breakdown Data by Countries
6.4.1 North America Drugs for Malaria Sales by Countries
6.4.2 North America Drugs for Malaria Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Drugs for Malaria Breakdown Data by Company
7.2 Europe Drugs for Malaria Breakdown Data by Type
7.3 Europe Drugs for Malaria Breakdown Data by Application
7.4 Europe Drugs for Malaria Breakdown Data by Countries
7.4.1 Europe Drugs for Malaria Sales by Countries
7.4.2 Europe Drugs for Malaria Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Drugs for Malaria Breakdown Data by Company
8.2 Asia Pacific Drugs for Malaria Breakdown Data by Type
8.3 Asia Pacific Drugs for Malaria Breakdown Data by Application
8.4 Asia Pacific Drugs for Malaria Breakdown Data by Regions
8.4.1 Asia Pacific Drugs for Malaria Sales by Regions
8.4.2 Asia Pacific Drugs for Malaria Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Drugs for Malaria Breakdown Data by Company
9.2 Latin America Drugs for Malaria Breakdown Data by Type
9.3 Latin America Drugs for Malaria Breakdown Data by Application
9.4 Latin America Drugs for Malaria Breakdown Data by Countries
9.4.1 Latin America Drugs for Malaria Sales by Countries
9.4.2 Latin America Drugs for Malaria Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Drugs for Malaria Breakdown Data by Type
10.2 Middle East and Africa Drugs for Malaria Breakdown Data by Application
10.3 Middle East and Africa Drugs for Malaria Breakdown Data by Countries
10.3.1 Middle East and Africa Drugs for Malaria Sales by Countries
10.3.2 Middle East and Africa Drugs for Malaria Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Cipla
11.1.1 Cipla Corporation Information
11.1.2 Cipla Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Cipla Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Cipla Drugs for Malaria Products and Services
11.1.5 Cipla SWOT Analysis
11.1.6 Cipla Recent Developments
11.2 Guilin Pharmaceutical
11.2.1 Guilin Pharmaceutical Corporation Information
11.2.2 Guilin Pharmaceutical Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Guilin Pharmaceutical Drugs for Malaria Products and Services
11.2.5 Guilin Pharmaceutical SWOT Analysis
11.2.6 Guilin Pharmaceutical Recent Developments
11.3 IPCA Laboratories
11.3.1 IPCA Laboratories Corporation Information
11.3.2 IPCA Laboratories Business Overview and Total Revenue (2019 VS 2018)
11.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 IPCA Laboratories Drugs for Malaria Products and Services
11.3.5 IPCA Laboratories SWOT Analysis
11.3.6 IPCA Laboratories Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Corporation Information
11.4.2 GlaxoSmithKline Business Overview and Total Revenue (2019 VS 2018)
11.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 GlaxoSmithKline Drugs for Malaria Products and Services
11.4.5 GlaxoSmithKline SWOT Analysis
11.4.6 GlaxoSmithKline Recent Developments
11.5 Mylan Labs
11.5.1 Mylan Labs Corporation Information
11.5.2 Mylan Labs Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Mylan Labs Drugs for Malaria Products and Services
11.5.5 Mylan Labs SWOT Analysis
11.5.6 Mylan Labs Recent Developments
11.6 Roche
11.6.1 Roche Corporation Information
11.6.2 Roche Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Roche Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Roche Drugs for Malaria Products and Services
11.6.5 Roche SWOT Analysis
11.6.6 Roche Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Novartis Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Novartis Drugs for Malaria Products and Services
11.7.5 Novartis SWOT Analysis
11.7.6 Novartis Recent Developments
11.8 Sanofi Aventis
11.8.1 Sanofi Aventis Corporation Information
11.8.2 Sanofi Aventis Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Sanofi Aventis Drugs for Malaria Products and Services
11.8.5 Sanofi Aventis SWOT Analysis
11.8.6 Sanofi Aventis Recent Developments
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Corporation Information
11.9.2 Ajanta Pharma Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Ajanta Pharma Drugs for Malaria Products and Services
11.9.5 Ajanta Pharma SWOT Analysis
11.9.6 Ajanta Pharma Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Drugs for Malaria Sales Channels
12.2.2 Drugs for Malaria Distributors
12.3 Drugs for Malaria Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Drugs for Malaria Sales Forecast (2021-2026)
13.1.1 Global Drugs for Malaria Sales Forecast by Regions (2021-2026)
13.1.2 Global Drugs for Malaria Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Drugs for Malaria Sales Forecast (2021-2026)
13.2.2 North America Drugs for Malaria Revenue Forecast (2021-2026)
13.2.3 North America Drugs for Malaria Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Drugs for Malaria Sales Forecast (2021-2026)
13.3.2 Europe Drugs for Malaria Revenue Forecast (2021-2026)
13.3.3 Europe Drugs for Malaria Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Drugs for Malaria Sales Forecast (2021-2026)
13.4.2 Asia Pacific Drugs for Malaria Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Drugs for Malaria Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Drugs for Malaria Sales Forecast (2021-2026)
13.5.2 Latin America Drugs for Malaria Revenue Forecast (2021-2026)
13.5.3 Latin America Drugs for Malaria Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Drugs for Malaria Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Drugs for Malaria Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Drugs for Malaria Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

Data is Ready Buy This Premium Report @ http://www.amecoresearch.com/buy/200880

About Us:      

Ameco Research is the one spot destination for all your research needs. Ameco Research holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making a purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Contact:

Website: www.amecoresearch.com

Email: sales@amecoresearch.com | +1 407 915 4157

Follow Us:-

Linkedin: https://www.linkedin.com/company/ameco-research

Twitter: https://twitter.com/AmecoResearch